Global Information
회사소개 | 문의 | 비교리스트

북미 및 유럽의 전임상 의료기기 검사 서비스 시장 : 서비스별(생체적합성 검사, 화학 검사) 시장 규모, 점유율 및 동향 분석, 부문별 예측(2021-2028년)

North America And Europe Preclinical Medical Device Testing Services Market Size, Share & Trends Analysis Report By Services (Biocompatibility Tests, Chemistry Test), And Segment Forecasts, 2021 - 2028

리서치사 Grand View Research, Inc.
발행일 2021년 12월 상품코드 1044737
페이지 정보 영문 100 Pages 배송안내 2-10일 (영업일 기준)
가격
US $ 5,950 ₩ 7,581,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,855,000 Printable PDF (5-User License)
US $ 8,950 ₩ 11,404,000 Printable PDF (Enterprise License)


북미 및 유럽의 전임상 의료기기 검사 서비스 시장 : 서비스별(생체적합성 검사, 화학 검사) 시장 규모, 점유율 및 동향 분석, 부문별 예측(2021-2028년) North America And Europe Preclinical Medical Device Testing Services Market Size, Share & Trends Analysis Report By Services (Biocompatibility Tests, Chemistry Test), And Segment Forecasts, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문 100 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

북미 및 유럽의 전임상 의료기기 검사 서비스 시장 규모는 2028년까지 56억 달러에 달할 전망입니다.

2020년에는 11.2%의 CAGR로 확대될 것으로 예측됩니다. COVID-19는 의료기기의 거대한 수요를 창출하고 있으며, 이 동향은 향후에도 지속될 것으로 생각됩니다. 이 시장의 주요 요인은 의료기기에 대한 규제가 엄격해지고 있는 점이며, 정밀하고 혁신적인 기기의 형성에 도움이 될 것으로 기대되고 있습니다.

북미 및 유럽의 전임상 의료기기 검사 서비스(Preclinical Medical Device Testing Services) 시장에 대해 조사 분석했으며, 시장 및 업계 전망, 부문별·지역별 시장 전망 등, 경쟁 상황에 대한 체계적인 정보를 제공합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 북미 및 유럽의 전임상 의료기기 검사 서비스 시장 변수, 동향 및 범위

  • 시장 계통 전망
  • 침투와 성장 전망 매핑
  • 시장 역학
  • 북미 및 유럽의 전임상 의료기기 검사 서비스 : 시장 분석 툴
  • 임상시험 활동에 대한 COVID-19 팬데믹의 영향

제4장 북미 및 유럽의 전임상 의료기기 검사 서비스 : 부문 분석, 서비스별, 2016-2028년(백만 달러)

  • 부문 대시보드
  • 연구 설계 시장 점유율 분석, 2020년 및 2028년
  • 북미 및 유럽의 전임상 의료기기 검사 서비스, 서비스별, 2016-2028년
  • 시장 규모와 예측 및 동향 분석, 2016-2028년
    • 생체적합성 검사
    • 화학 검사
    • 미생물 검사와 무균성
    • 패키지 검증

제5장 북미 및 유럽의 전임상 의료기기 검사 서비스 : 지역별 시장 분석, 2016-2028년(백만 달러)

  • 지역 시장 대시보드
  • 지역 시장 점유율 분석, 2020년 및 2028년
  • 시장 규모, 예측 및 동향 분석, 2016-2028년
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 벨기에
    • 스위스
    • 러시아
    • 스웨덴

제6장 북미 및 유럽의 전임상 의료기기 검사 서비스 시장 - 경쟁 분석

  • 주요 기업 개요
    • SGS SA
    • Toxikon Inc.
    • Eurofins Scientific
    • Pace Analytical Services, Inc.
    • WuXiAppTec, Inc.
    • North American Science Associates, Inc.
    • TUV SUD A.G.
    • American Preclinical Services
    • Sterigenics International LLC
    • Charles River Laboratories International, Inc.
    • Nelson Labs
KSM 22.01.24

List of Tables

  • Table 1 North America & Europe Preclinical Medical Device Testing Services Market, by Region, 2016 - 2028 (USD Million)
  • Table 2 North America & Europe Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 3 North America & Europe Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 4 North America Preclinical Medical Device Testing Services Market, by Region, 2016 - 2028 (USD Million)
  • Table 5 North America Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 6 North America Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 7 U.S. Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 8 U.S. Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 9 Canada Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 10 Canada Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 11 Europe Preclinical Medical Device Testing Services Market, by Region, 2016 - 2028 (USD Million)
  • Table 12 Europe Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 13 Europe Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 14 U.K. Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 15 U.K. Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 16 Germany Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 17 Germany Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 18 France Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 19 France Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 20 Italy Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 21 Italy Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 22 Spain Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 23 Spain Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 24 Netherlands Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 25 Netherlands Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 26 Belgium Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 27 Belgium Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 28 Switzerland Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 29 Switzerland Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 30 Russia Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 31 Russia Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
  • Table 32 Sweden Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
  • Table 33 Sweden Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 North America & Europe preclinical medical device testing services: Market snapshot
  • Fig. 8 North America & Europe preclinical medical device testing services: Market segmentation
  • Fig. 9 North America & Europe preclinical medical device testing services market strategy framework
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 North America & Europe preclinical medical device testing services market driver impact
  • Fig. 13 North America & Europe preclinical medical device testing services restraint impact
  • Fig. 14 North America & Europe preclinical medical device testing services market porter's five forces analysis
  • Fig. 15 North America & Europe preclinical medical device testing services market PESTEL analysis
  • Fig. 16 North America & Europe preclinical medical device testing services market: services segment dashboard
  • Fig. 17 North America & Europe preclinical medical device testing services market: service movement analysis
  • Fig. 18 Biocompatibility tests market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 19 Chemistry test market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 20 Microbiology & sterility testing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 21 Package Validation market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 22 North America & Europe preclinical medical device testing services market: Segment dashboard
  • Fig. 23 North America & Europe preclinical medical device testing services market: test type movement analysis
  • Fig. 24 North America & Europe preclinical medical device testing services market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 25 Global North America & Europe preclinical medical device testing services market: Regional movement analysis
  • Fig. 26 Global North America & Europe preclinical medical device testing services market: Regional outlook and key takeaways
  • Fig. 27 North America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 28 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 29 Canada market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 30 Europe market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 31 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 32 Germany market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 33 France market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 34 Italy market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 35 Spain market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 36 Netherlands market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 37 Belgium market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 38 Switzerland market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 39 Russia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 40 Sweden market estimates and forecast, 2016 - 2028 (USD Million)

North America And Europe Preclinical Medical Device Testing Service Market Growth & Trends:

The North America and Europe preclinical medical device testing services market size is expected to reach USD 5.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.2% in 2020. COVID-19 has created a huge demand for medical devices and this trend is going to be followed in the coming years. The main driver of this market is the growing stringent regulations for medical devices that are expected to help in the formation of precise and innovative devices.

There has been an increase in the number of players operating in the market over the last decade. Due to this large number, it has witnessed fierce competition. To sustain the market, a mix of defensive and offensive marketing strategies is used. For instance, extensive R&D, competitive pricing, new product launches, collaborative development, regional expansion, and mergers and acquisitions.

COVID-19 has created a huge demand for these services. During the first half, the growth was not drastic, but it increased in the second half as the industry learned to operate amid the pandemic. Various projects that were postponed due to COVID have resumed and there has been a spike in production and testing of Personal Protective Equipment (PPE). There are many other medical devices in high demand during the pandemic, which shifted the focus from the devices required during surgery. The major products experiencing a surge in demand are the COVID-19 vaccines, ventilators, and pulse oximeters.

North America And Europe Preclinical Medical Device Testing Service Market Report Highlights:

  • The chemistry test is expected to witness a CAGR of 11.5% over the forecasted period as they help in checking the safety parameters of medical devices
  • The sterility test and validation segment accounted for the largest revenue share of 45.6% and is expected to witness a CAGR of 11.3% over the forecast period
  • North America accounted for the largest revenue share of 54.9% in 2020. This is due to the large number of market players operating in the region
  • In Europe, the market is expected to witness a CAGR of 11.2% over the forecast period. This is due to rising demand for cost-cutting and increasing complexity in product designing

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Study design
    • 1.1.2. Indication
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America & Europe Preclinical Medical Device Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Complexity in Product design
      • 3.3.1.2. Intensifying Competition
      • 3.3.1.3. Increase in number of small medical device lacking in-house testing capabilities
      • 3.3.1.4. Strict Approval Norms
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Legal and Regulatory Issues
      • 3.3.2.2. Delays in contractual obligation
    • 3.3.3. Industry Challenges
  • 3.4. North America & Europe Preclinical Medical Device Testing Services: Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier Power
      • 3.4.1.2. Buyer Power
      • 3.4.1.3. Substitution Threat
      • 3.4.1.4. Threat from new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
  • 3.5. COVID-19 pandemic impact on clinical trial activity

Chapter 4. North America & Europe Preclinical Medical Device Testing Services: Segment Analysis, By services, 2016 - 2028 (USD Million)

  • 4.1. Segment Dashboard
  • 4.2. Study Design Market Share Analysis, 2020&2028
  • 4.3. Global North America & Europe Preclinical Medical Device Testing Services, By services, 2016 to 2028
  • 4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028for the following
    • 4.4.1. Biocompatibility Test
    • 4.4.2. Chemistry Test
    • 4.4.3. Microbiology Test & Sterility
      • 4.4.3.1. Bioburden Determination
      • 4.4.3.2. Pyrogen & Endotoxin Testing
      • 4.4.3.3. Sterility Test and Validation
      • 4.4.3.4. Antimicrobial activity testing
      • 4.4.4.4. Others
    • 4.4.4. Package Validation

Chapter 5. North America & Europe Preclinical Medical Device Testing Services: Regional Market Analysis, by region, 2016 - 2028 (USD Million)

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2020&2028
  • 5.3. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
  • 5.4. North America
    • 5.4.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 5.4.2. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
    • 5.4.3. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.4.4. U.S.
      • 5.4.4.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.4.4.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.4.5. Canada
      • 5.4.5.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.4.5.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
  • 5.5. Europe
    • 5.5.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 5.5.2. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
    • 5.5.3. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.4. Germany
      • 5.5.4.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.4.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.5. U.K.
      • 5.5.5.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.5.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.6. France
      • 5.5.6.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.6.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.7. Italy
      • 5.5.7.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.7.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.8. Spain
      • 5.5.8.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.8.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.9. Netherlands
      • 5.5.9.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.9.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.10. Belgium
      • 5.5.10.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.10.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.11. Switzerland
      • 5.5.11.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.11.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.12. Russia
      • 5.5.12.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.12.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
    • 5.5.13. Sweden
      • 5.5.13.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
      • 5.5.13.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)

Chapter 6. North America & Europe Preclinical Medical Device Testing Services Market - Competitive Analysis

  • 6.1. Key companies profiled
    • 6.1.1. SGS SA
      • 6.1.1.1. Company Overview
      • 6.1.1.2. Financial Performance
      • 6.1.1.3. Product Benchmarking
      • 6.1.1.4. Strategic Initiatives
    • 6.1.2. Toxikon Inc.
      • 6.1.2.1. Company Overview
      • 6.1.2.2. Financial Performance
      • 6.1.2.3. Product Benchmarking
      • 6.1.2.4. Strategic Initiatives
    • 6.1.3. Eurofins Scientific
      • 6.1.3.1. Company Overview
      • 6.1.3.2. Financial Performance
      • 6.1.3.3. Product Benchmarking
      • 6.1.3.4. Strategic Initiatives
    • 6.1.4. Pace Analytical Services, Inc.
      • 6.1.4.1. Company Overview
      • 6.1.4.2. Financial Performance
      • 6.1.4.3. Product Benchmarking
      • 6.1.4.4. Strategic Initiatives
    • 6.1.5. WuXiAppTec, Inc.
      • 6.1.5.1. Company Overview
      • 6.1.5.2. Financial Performance
      • 6.1.5.3. Product Benchmarking
      • 6.1.5.4. Strategic Initiatives
    • 6.1.6. North American Science Associates, Inc.
      • 6.1.6.1. Company Overview
      • 6.1.6.2. Financial Performance
      • 6.1.6.3. Product Benchmarking
      • 6.1.6.4. Strategic Initiatives
    • 6.1.7. TUV SUD A.G.
      • 6.1.7.1. Company Overview
      • 6.1.7.2. Financial Performance
      • 6.1.7.3. Product Benchmarking
      • 6.1.7.4. Strategic Initiatives
    • 6.1.8. American Preclinical Services
      • 6.1.8.1. Company Overview
      • 6.1.8.2. Financial Performance
      • 6.1.8.3. Product Benchmarking
      • 6.1.8.4. Strategic Initiatives
    • 6.1.9. Sterigenics International LLC
      • 6.1.9.1. Company Overview
      • 6.1.9.2. Financial Performance
      • 6.1.9.3. Product Benchmarking
      • 6.1.9.4. Strategic Initiatives
    • 6.1.10. Charles River Laboratories International, Inc.
      • 6.1.10.1. Company Overview
      • 6.1.10.2. Financial Performance
      • 6.1.10.3. Product Benchmarking
      • 6.1.10.4. Strategic Initiatives
    • 6.1.11. Nelson Labs
      • 6.1.11.1. Company Overview
      • 6.1.11.2. Financial Performance
      • 6.1.11.3. Product Benchmarking
      • 6.1.11.4. Strategic Initiatives
Back to Top
전화 문의
F A Q